| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.0M | +5.8% |
| Cost of Revenue | $1.8M | +33.2% |
| Gross Profit | $18.2M | +3.6% |
| R&D Expense | $3.9M | -17.6% |
| SG&A Expense | $15.5M | +2.3% |
| Operating Income | -$1.2M | +48.7% |
| Pre-tax Income | -$885K | +56.7% |
| Income Tax | $33K | +153.2% |
| Net Income | -$918K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.7M | +17.2% |
| Accounts Receivable | $4.7M | -0.6% |
| Current Assets | $9.9M | -31.0% |
| Total Assets | $20.9M | -12.1% |
| Current Liabilities | $3.2M | -51.2% |
| Total Liabilities | $3.2M | -51.2% |
| Stockholders' Equity | $17.7M | +2.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.7M | -316.4% |
| Capital Expenditures | $57K | -38.7% |
| Investing Cash Flow | $2.9M | +799.3% |
| Financing Cash Flow | $485K | +412.9% |
| Free Cash Flow | -$2.8M | -271.8% |
| +53.6% |
| EPS (Basic) | -$0.05 | +50.0% |
| EPS (Diluted) | -$0.05 | +50.0% |